What Are the Challenges in Using Nanotechnology for CF?
While nanotechnology holds promise for CF treatment, several challenges must be addressed:
Toxicity: The safety profile of nanomaterials must be thoroughly evaluated to avoid potential toxicity, particularly in long-term applications. Delivery Efficiency: Achieving efficient and selective delivery of nanoparticles to the target cells in the lungs is a significant challenge due to biological barriers such as mucus and immune clearance. Scalability: The production and scalability of nanomaterials for clinical use must be optimized to ensure consistency and cost-effectiveness.
